Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed

被引：1
|
作者：
Nummi, Vuokko [1 ,2 ,3 ]
Lehtinen, Elina [2 ,3 ]
Makipernaa, Anne [2 ,3 ]
Szanto, Timea [4 ]
Lassila, Riitta [1 ,2 ,3 ]
机构：
[1] Univ Helsinki, Fac Med, Helsinki, Finland
[2] Helsinki Univ Hosp, Dept Hematol, Coagulat Disorder Unit, Helsinki, Finland
[3] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland
[4] Helsinki Univ Hosp, HUSLAB Lab Serv, Dept Clin Chem, Coagulat Disorder Unit, Helsinki, Finland
来源：
HAEMOPHILIA | 2019年 / 25卷 / 04期
关键词：
ANTIBODIES;
D O I：
10.1111/hae.13765
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E291 / E293
页数：3
相关论文
共 50 条
  • [1] MANAGEMENT OF A LIFE-THREATENING BLEED IN VON WILLEBRAND DISEASE
    Forsyth, K.
    Fenton, R.
    Morris, A.
    Yussuf, Z.
    Foley, C.
    Diona, L.
    Sivapalaratnam, S.
    McDonald, V.
    Raheja, P.
    HAEMOPHILIA, 2023, 29 : 146 - 146
  • [2] Life threatening recurrent gastrointestinal bleeding in a patient with type III von Willebrand disease: Successful treatment with propranolol
    Karaman, S.
    Unuvar, A.
    Tugcu, D.
    Onal, Z.
    Soysal, F. G.
    Ocak, S.
    Tuna, R.
    Karakas, Z.
    HAEMOPHILIA, 2019, 25 : 171 - 171
  • [3] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [4] Efficacy of emicizumab in a pediatric patient with type 3 von Willebrand disease and alloantibodies
    Weyand, Angela C.
    Flood, Veronica H.
    Shavit, Jordan A.
    Pipe, Steven W.
    BLOOD ADVANCES, 2019, 3 (18) : 2748 - 2750
  • [5] Life-threatening bleeding in a patient with mild hemophilia A and heterozygosity for von Willebrand disease Type 2N
    John N. Allan
    Kenneth D. Friedman
    Maria T. DeSancho
    International Journal of Hematology, 2014, 100 : 602 - 606
  • [6] Life-threatening bleeding in a patient with mild hemophilia A and heterozygosity for von Willebrand disease Type 2N
    Allan, John N.
    Friedman, Kenneth D.
    DeSancho, Maria T.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (06) : 602 - 606
  • [7] Treatment for patients with type 3 von Willebrand disease and alloantibodies: a case report
    Franchini, M.
    Gandini, G.
    Giuffrida, A.
    De Gironcoli, M.
    Federici, A. B.
    HAEMOPHILIA, 2008, 14 (03) : 645 - 646
  • [8] Management of pregnancy in type 3 von Willebrand disease with alloantibodies
    Scott, Martin
    Hay, Charles R. M.
    Elkhalifa, Shuayb
    Tower, Clare
    Cocker, Michael
    Thachil, Jecko
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (03) : 440 - 442
  • [9] Treatment of acute haemorrhage in a patient with type 3 von Willebrand's disease and alloantibodies against von Willebrand factor with recombinant activated factor VII
    Dietrich A.
    Scholz U.
    Schreiter D.
    European Surgery, 2005, 37 (6) : 336 - 339
  • [10] Effectiveness of emicizumab in preventing life-threatening bleeding complications in type 3 von Willebrand disease with inhibitors: A paediatric report
    Cefalo, Maria Giuseppina
    Ronco, Francesca
    Di Felice, Giovina
    Rinelli, Martina
    Oriana, Vincenzo
    Massoud, Michela
    Merli, Pietro
    Luciani, Matteo
    HAEMOPHILIA, 2021, 27 (04) : E495 - E497
12345